Company Overview of Mithridion, Inc.
Mithridion, Inc., a biopharmaceutical company, discovers and develops drugs for central nervous system disorders. Its products include MCD-386 Pharmacology, a selective M1 muscarinic agonist for alzheimer’s disease. The company’s drugs are used for the treatment of alzheimer’s disease and schizophrenia. Mithridion, Inc. was founded in 2004 and is based in Madison, Wisconsin.
505 Science Drive
Madison, WI 53711
Founded in 2004
Key Executives for Mithridion, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Mithridion, Inc., please visit www.mithridion.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.